T1	Outcomes 75 101	early virological response
T2	Outcomes 276 308	early virological response (EVR)
T3	Outcomes 731 738	HCV RNA
T4	Outcomes 788 826	Ribavirin plasma trough concentrations
T5	Outcomes 984 1051	nucleoside reverse transcriptase inhibitor (NRTI)-sparing regimens.
T6	Outcomes 1078 1094	HCV RNA decrease
T7	Outcomes 1172 1181	EVR rates
T8	Outcomes 1303 1319	HCV RNA decrease
T9	Outcomes 1370 1378	RBV-C(4)
T10	Outcomes 1569 1588	decrease in HCV RNA
T11	Outcomes 1644 1654	EVR rates.
T12	Outcomes 1740 1762	HCV treatment efficacy